文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重症监护病房机械通气患者拔管后序贯经鼻高流量氧疗的效果分析

[Analysis of the effect of sequential high-flow nasal canula oxygen therapy in post-extubation mechanically ventilated patients in intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论ICU机械通气患者拔管后序贯HFNC可降低撤机失败率、缩短总机械通气时间和ICU住院时间,但不降低ICU死亡率。

前瞻性研究纳入163例ICU机械通气患者,拔管后分为HFNC组(82例)和传统氧疗组(81例)。HFNC组撤机失败率显著低于传统氧疗组(4.9% vs 16.0%,P<0.05),总机械通气时间和ICU住院时间显著缩短,再插管时间显著延长。两组ICU死亡率和住院时间无显著差异。提示ICU机械通气患者拔管后序贯HFNC可减少撤机失败和不良事件,缩短ICU住院时间。

要点

  • 拔管后序贯HFNC较传统氧疗显著降低撤机失败率(4.9% vs 16.0%,P<0.05)。
  • HFNC组总机械通气时间(4.48±2.43天 vs 5.67±3.84天)和ICU住院时间(6.57天 vs 7.74天)显著短于传统氧疗组。
  • HFNC组再插管时间显著长于传统氧疗组(35.75±10.15小时 vs 19.92±13.12小时,P<0.05)。
  • 传统氧疗组气道分泌物清除能力低下的撤机失败比例显著高于HFNC组(8.64% vs 0%,P<0.05)。
  • 两组ICU死亡率(4.9% vs 3.7%)和住院时间无显著差异(P>0.05)。

适用人群与场景

  • ICU收治的机械通气患者,拔管后序贯氧疗;研究纳入2018年1月至2020年6月皖南医学院弋矶山医院ICU的163例患者,排除标准原文未提及。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • HFNC组:拔管后使用经鼻高流量湿化治疗仪,气流从35 L/min根据耐受逐渐增至60 L/min,温度设置34-37℃,根据SpO2设置FiO2,维持SpO2在0.95-0.98。
  • 传统氧疗组:拔管后使用一次性氧气面罩或鼻导管吸氧,氧流量5-8 L/min,维持SpO2在0.95-0.98。
  • 两组均根据病情给予常规治疗。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 前瞻性研究,单中心,纳入163例ICU机械通气患者,HFNC组82例,传统氧疗组81例;主要终点拔管后撤机失败率HFNC组显著低于传统氧疗组(4.9% vs 16.0%,P<0.05)。
  • 总机械通气时间HFNC组显著短于传统氧疗组(4.48±2.43天 vs 5.67±3.84天,P<0.05),ICU住院时间HFNC组显著短于传统氧疗组(6.57天 vs 7.74天,P<0.05)。
  • 再插管时间HFNC组显著长于传统氧疗组(35.75±10.15小时 vs 19.92±13.12小时,P<0.05)。
  • 撤机失败原因中,传统氧疗组气道分泌物清除能力低下比例显著高于HFNC组(8.64% vs 0%,P<0.05);心力衰竭、呼吸肌无力、低氧血症、意识改变两组无显著差异。
  • 拔管前机械通气时间(4.33±3.83天 vs 4.15±3.03天)、气管插管时间(4.34±1.87天 vs 4.20±3.35天)、ICU死亡率(4.9% vs 3.7%)和住院时间(28.93天 vs 27.69天)两组无显著差异(P>0.05)。

证据类型、等级与局限

  • 前瞻性研究,单中心,样本量163例,非随机分组(根据氧疗模式分组),开放标签;局限包括单中心、样本量有限、非随机设计可能引入选择偏倚。

对床旁实践的改变

  • 对ICU机械通气拔管后患者,可考虑序贯HFNC以降低撤机失败率、缩短总机械通气时间和ICU住院时间;不适用于需要立即再插管或HFNC禁忌者(原文未列出具体禁忌)。
  • HFNC参数设置可参考原文:气流35-60 L/min,温度34-37℃,维持SpO2 0.95-0.98;传统氧疗流量5-8 L/min维持相同SpO2目标。
  • 需注意HFNC可能延长再插管时间,应密切监测避免延误再插管。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To observe the application effect of high-flow nasal canula oxygen therapy (HFNC) after extubation in patients with mechanical ventilation (MV) in the intensive care unit (ICU).

METHODS: A prospective study was conducted. From January 2018 to June 2020, 163 MV patients admitted to Yijishan Hospital of Wannan Medical College were enrolled, and they were divided into HFNC group (82 cases) and traditional oxygen therapy group (81 cases) according to the oxygen therapy model. The patients included in the study were given conventional treatment according to their condition. In the HFNC group, oxygen was inhaled by a nasal high-flow humidification therapy instrument. The gas flow was gradually increased from 35 L/min to 60 L/min according to the patient's tolerance, and the temperature was set at 34-37 centigrade. The fraction of inspiration oxygen (FiO2) was set according to the patient's pulse oxygen saturation (SpO2) and SpO2 was maintained at 0.95-0.98. A disposable oxygen mask or nasal cannula was used to inhale oxygen in the traditional oxygen therapy group, and the oxygen flow was 5-8 L/min, maintaining the patient's SpO2 at 0.95-0.98. The differences in MV duration before extubation, total MV duration, intubation time, reintubation time, extubation failure rate, ICU mortality, ICU stay, and in-hospital stay were compared between the two groups, and weaning failure were analyzed.

RESULTS: There was no significant differences in MV duration before extubation (days: 4.33±3.83 vs. 4.15±3.03), tracheal intubation duration (days: 4.34±1.87 vs. 4.20±3.35), ICU mortality [4.9% (4/82) vs. 3.7% (3/81)] and in-hospital stay [days: 28.93 (15.00, 32.00) vs. 27.69 (15.00, 38.00)] between HFNC group and traditional oxygen therapy group (all P > 0.05). The total MV duration in the HFNC group (days: 4.48±2.43 vs. 5.67±3.84) and ICU stay [days: 6.57 (4.00, 7.00) vs. 7.74 (5.00, 9.00)] were significantly shorter than those in the traditional oxygen therapy group, the reintubation duration of the HFNC group was significantly longer than that of the traditional oxygen therapy group (hours: 35.75±10.15 vs. 19.92±13.12), and the weaning failure rate was significantly lower than that of the traditional oxygen therapy group [4.9% (4/82) vs. 16.0% (13/81), all P < 0.05]. Among the reasons for weaning failure traditional oxygen therapy group had lower ability of airway secretion clearance than that of the HFNC group [8.64% (7/81) vs. 0% (0/82), P < 0.05], there was no statistically differences in the morbidity of heart failure, respiratory muscle weakness, hypoxemia, and change of consciousness between the two groups.

CONCLUSIONS: For MV patients in the ICU, the sequential application of HFNC after extubation can reduce the rate of weaning failure and the incidence of adverse events, shorten the length of ICU stay.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhang P, Li Z, Jiang H, et al. [Analysis of the effect of sequential high-flow nasal canula oxygen therapy in post-extubation mechanically ventilated patients in intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34296688. doi:10.3760/cma.j.cn121430-20210116-00074

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。